LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,287,009 | -24.4% | 6,726,496 | 0.0% | 0.07% | -20.0% |
Q4 2022 | $3,026,923 | -54.0% | 6,726,496 | -10.0% | 0.08% | -55.5% |
Q3 2022 | $6,575,000 | -28.1% | 7,472,148 | -6.0% | 0.19% | -33.2% |
Q2 2022 | $9,144,000 | -34.3% | 7,951,448 | 0.0% | 0.29% | +2.5% |
Q1 2022 | $13,915,000 | -74.7% | 7,951,448 | -53.1% | 0.28% | -34.2% |
Q4 2021 | $54,926,000 | +61.6% | 16,952,992 | +100.0% | 0.42% | -14.2% |
Q3 2021 | $33,990,000 | +22.3% | 8,476,496 | -50.0% | 0.49% | +172.9% |
Q2 2021 | $27,802,000 | +72.6% | 16,952,992 | +100.0% | 0.18% | -11.3% |
Q1 2021 | $16,105,000 | -15.6% | 8,476,496 | 0.0% | 0.20% | -0.5% |
Q4 2020 | $19,072,000 | +13.6% | 8,476,496 | 0.0% | 0.20% | -16.3% |
Q3 2020 | $16,783,000 | -3.9% | 8,476,496 | 0.0% | 0.24% | -13.4% |
Q2 2020 | $17,466,000 | +64.4% | 8,476,496 | +26.0% | 0.28% | +2.2% |
Q1 2020 | $10,627,000 | – | 6,726,496 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 900,733 | $1,883,000 | 1.44% |
Sio Capital Management, LLC | 1,501,998 | $3,139,000 | 0.92% |
CVI Holdings, LLC | 704,900 | $1,473,000 | 0.55% |
Perceptive Advisors | 8,476,496 | $17,466,000 | 0.28% |
Artal Group S.A. | 2,974,000 | $6,216,000 | 0.17% |
SPHERA FUNDS MANAGEMENT LTD. | 880,000 | $1,839,000 | 0.17% |
DAFNA Capital Management LLC | 275,000 | $575,000 | 0.17% |
J. Goldman & Co LP | 1,018,285 | $2,128,000 | 0.13% |
MYDA Advisors LLC | 100,000 | $209,000 | 0.13% |
683 Capital Management, LLC | 526,466 | $1,100,000 | 0.09% |